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INTRODUCTION 
The acid-sensing ion channels or ASICs form a distinc  
branch of  he degenerin superfamily (ENaC/DEG) of 
sodium channels. A  leas  four ASIC genes have been 
identified in humans so far, numbered 1–4, wi h a 
number of splice varian s encoding a  o al of nine 
unique pro eins [1-9]. The channels formed by  he 
ASIC pro eins are basically pro on-ga ed cation chan-
nels, opening rapidly in  he presence of ex racellular 
acid. All ASIC subuni  consis s of a large ex racellular 
domain, 2  ransmembrane helices, and shor  cy oplas-
mic N and C  ermini. Functional ASICs are homo or 
he ero rimers of ASIC1a, ASIC1bASIC2a, ASIC2b, and/
or ASIC3 subuni s [10-11]. ASIC2b is no  functional as 
homomultimer bu  form functional he eromeric chan-
nels in combination wi h o her subuni s [12]. The 
activi y of ASIC4 channel has been de ec ed very 
limi ed ye . I  may participa e in regulating  he mem-
brane availabili y of o her ASIC subuni s [13]. ASIC1a 
and ASIC3 are activa ed by an acidi y range (pH 7.0-
6.0) observed in several acu e and chronic pain condi-
tions. ASIC3 is particularly sensitive  o lactic acidosis 
and  hus is considered  o be an impor an  componen  
of acid induced pain [14]. 
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I  has been noticed  ha   he activation of ASIC in 
neurons induce action po entials. The ex en  and 
duration of  he ASIC-media ed depolarization depends 
bo h on ASIC ampli ude activi y and  he number of 
charges  he channels  ranspor  during  heir open-
ing [15-16]. Among all o hers, ASIC3  is   he  mos   
sensitive   o  increases  in  pro on  concen ration,  wi h  
half-maximal  pH activation is 6.4 [17]. ASIC2 is  he 
leas  sensitive, requiring exposure  o pH 4.5 for half-
maximal activation. ASICs have been de ec ed 
 hroughou   he nervous sys em, specifically in areas 
of high synaptic densi y, localizing primarily  o  he 
soma and processes of neurons [18-19]. Their expres-
sion pattern has sugges ed  ha   hese channels 
play a role in sensory perception and various neural 
processes [20-21]. ASICs have widespread dis ribution 
 o many regions in  he nervous sys em including dor-
sal roo  ganglia, cor ex, hippocampus, basal ganglia, 
amygdale, olfac ory bulb, cerebrum and elsewhere [22
-24].  In erestingly, ASICs are increasingly being de ec -
ed in nonneuronal settings including cancer cells 
[25], bone [26], in estinal and bladder epi helium 
cells and smoo h muscle [27-30]. Because ASICs are 
permeable  o Na+,  heir activation leads  o mem-
brane depolarization,  hus inducing action po entials 
in neurons ASICs often have an activation effec  on 
neurons. A s rong ASIC-media ed depolarization, how-
ever, can inhibi  an already actively signaling neuron. 
ASIC1a has a small permeabili y for Ca2+ in addition  o 
i s Na+ permeabili y, and some of i s cellular func-
tions, as for example neurodegeneration after ischem-
ABSTRACT 
Acid sensing ion channels (ASIC) are Na+ channels activa ed by ex ernal pro ons.  Number of neurological 
(pa hological pain, expression of fear, anxie y, depression, and neurodegeneration after ischemic s roke e c) and non
-neurological (brain  umor, cardiovascular mechanosensation, hypoxia induced hyper ension, glaucoma, e c.) disor-
ders are implica ed by various ASICs sub ypes. Due  o  heir known and po ential roles in many disease pa hologies, i  
is very au hentic  o explore  he impor ance of new and selective small molecule inhibi ors and even activa ors of 
ASICs as a research  ool in clinical uses for  reating  hese diseases pa hogenesis. This review is aimed  o find ou   he 
 herapeutic po entialities of ASICs  arge ed novel drugs in con ex  of  heir pa hophysiological role in human body. 
Fluorescen  dyes and optical sensors as a means of fas  and efficien  screening approaches would cer ainly be used 
 o improve  he discovery  echnology of ASICs modula ed drugs. 
Keywords: Acid, ion channel, discovery, pharmacological, disease. 
 







ic s roke are  hough   o depend on a Ca2+    en ry 
in o  he cell [31-36]. Expression pattern of ASIC 
subuni s in differen  cells and tissue  ypes of function-
al organization are represen ed in Table 1. 
2. Pathophysiological role of acid-sensing ion channels 
The abundance of ASICs in human body and  heir 
associa ed causative disorders are recen ly discov-
ered by a wide range of research expertise.  I  is in-
 eresting  o observe  ha  bo h neurological and non-
neurological pa hologies  hese channels have been 
con ribu ed equally  o play  heir role. 
2.1. Synaptic plastici y and learning: I  is consis en  
wi h ASIC1a induced pos synaptic depolarization, and 
synaptic plastici y  ha , depending on  he brain area, 
 hey ei her promo e or inhibi  plastici y. 
2.2. Nociception and pain sensation: I  occurs in  he 
con ex  of inflammation, media ed by acid-evoked 
ASIC curren s in nociceptive neurons.  ASICs in sensory 
neurons are  herefore candida e recep ors for acidifi-
cation inducing pain. ASIC1a and ASIC2 are expressed 
in pain-processing areas of  he CNS whereas peripheral 
ASIC3 and ASIC1 are involved in pain sensation. ASIC3 
is responsible for chronic acidification rela ed forms of 
pain and inflammation. In er leukin-1 (IL-1), bradykin-
in and especially NGF, are called pro inflamma ory 
media ors can enhance ASIC3 expression a   he  ran-
scriptional level which is reflec ed by an increase in 
ASIC curren  in sensory neurons during pain sensation 
[37-38]. 
2.3. Fear and anxie y: I  is resul  of pH change expres-
sion and is particularly high in  he amygdale induced 
by ASIC1a. However, overexpression of ASIC1a in-
creased fear rela ed behavior. 
2.4. Mechanosensation: Mechanosensation in  he gas-
 roin estinal sys em is impor an  for  he con rol of gas-
 ric coordination and emp ying, colonic motili y, and 
 he sensation of pain. There is evidence of ASIC   
expression   in   primary   sensory   neurons   and    he   
afferen s   of   mechanoreception. He eromeric  
ASIC2a/ASIC2b  channel  has  been  implica ed  in  sour  
 as e  sensing  which essentially an acid  as e  ype. I  
has been eviden   ha   he activation of  he recep or by 
acid leads  o depolarization of  as e cells and  rans-
mitter release on o gus a ory afferen  neurons [39]. 
2.5. Neurodegenerative disorders: Ca2+ ion permeabil-
i y of ASIC1a and tissue acidification is play a role in 
a handful number of neurodegenerative disease, in-
cluding ischemic s roke [40], epileptic seizures [41-43] 
au oimmune encephalitis [44], Hunting on`s [45] and 
Parkinson`s disease [46-47].  I  has been proposed  ha  
blocking of ASICs gave a  herapeutic time window of 
more  han 5 h in ra  models of focal ischemia and 
 herefore makes  hem a grea   herapeutic  arge  for 
s roke  rea men  [48]. 
2.6. Angina pain: Angina pain and ischemic damage 
following cardiac arres  has been associa ed wi h ASIC3 
response in hear  muscle. This is due  o  he cell bodies 
of neurons via dorsal roo  ganglia (DRG)  owards hea  
responded  o very low pH [49-50]. Recen ly i  has 
Int. j. clin. biomed. res. 2018;4(1): 62-68. 
Tissue / Cell Type ASIC Subuni  
  1 2 3 4 
As rocy es x x x x 
Brain x x x   
Chondrocy es, in erver ebral discs x   x   
Dorsal roo  ganglia x x x x 
Esophagus x x x   
Gas roin estinal  rac  x x x   
Hear  neurons   x x   
Inner ear   x x   
Keratinocy es   x     
Lung, AT1/ ATII cells, bronchus, nasal epi helium, 
Calu-3 cells 
    x   
Nodose ganglia x x     
Os eoblas s x x x   
Pacinian corpuscles x x     
Retina x x x x 
Tas e buds x x x   
Vascular smoo h muscle x x x   
Table-1. Expression  pattern  of  ASIC  subunits  in  different  cells  and  tissue  types  of  their  
functional organization. 




been shown  ha   his kinetics in DRG more closely 
resemble wi h curren s associa ed wi h ASIC 2a/3 he -
eromers as well [51]. 
2.7. Developmen  of chronic hypoxia-induced pulmo-
nary hyper ension: Al hough i  is unknown whe her an 
increase in ASIC1-media ed Ca2+   influx has a role for 
developing pulmonary hyper ension bu   ASIC1  obvi-
ously con ribu es  o enhanced  recep or- media ed 
vasocons riction and s ore opera ed Ca2+  ion en ry in 
small pulmonary ar eries,  hereby ASIC1 activa es  o 
vasocons ric or and chronic hypoxia-induced pulmo-
nary hyper ension [52] . 
2.8: Cardiovascular mechanosensing and chemosensing 
regulation: The acid-sensing ion channel particularly 
ASIC1 and ASIC3 and  o a lesser ex en , ASIC2 pro eins 
may play more ubiqui ous roles in cardiovascular regu-
lation considered previously. Recen  findings sugges  
 ha  ASICs may ac  as mechanosensors and chemosen-
sors in ar erial barorecep or neurons of cardiovascular 
region. ASIC pro eins may be ac  as chemo  ransduc-
ers in cardiac muscle tissue  ha  can signal  o initia e 
ischemic pain [53-54]. 
2.9. Cancer cell grow h suppression: 
2.9.1. Salivary gland me as asis: In salivary gland carci-
noma cells, an ASIC2/3 he eromeric conduc ance has 
been observed  ha  were absen  in normal salivary 
gland epi helia [55]. To da e, in case of colonic and 
brain malignancies,  he involvemen  of ASICs were bes  
found. 
2.9.2. Gliomas: Gliomas are  he mos  common primary 
brain  umors wi h a complex biology charac erized by 
antigenic and genomic he erogenei y and  endency 
for invasion in o cen ral nervous sys em could 
diffusely infil ra e  he normal brain tissues. Large ami-
loride-sensitive Na+ curren s have been de ec ed in 
aggressive brain  umors while in normal and low 
grade as rocytic  umors  here is none. I  was shown 
 ha   he cells express bo h ASIC1 and ASIC2 whereas 
high grade as rocy oma express only ASIC1, indicating 
 ha  ASIC2 may function as a kind of ASIC curren  sup-
pressor and  herefore a  umor suppressor. ASIC2 is no  
found in  he plasma membrane of grade IV gliomas 
cells, called glioblas oma multiforme (GBM)  here-
by, ASIC2 Inhibi s  he Amiloride-sensitive curren  and 
migration of Glioma Cells in me as atic disease 
[25,56]. I  is shown  ha  an active degenerin mu an  of 
ASIC2 could be delivered by virus  o express malignan  
cells leading fas  cell dea h by initiating unregula ed 
influx of sodium ion [57]. A wide varie y of disease 
pa hologies in which ASICs are po ential  herapeutic 
 arge s of investigation (inhibition or a  activation 
s a e) are as follows in Table-2. 
Therapeutic Indication ASIC Subuni  
  1 2 3 4 
Angina     x   
Glioma (Tumor suppression) x x     
Cardiovascular regulation x   x   
Pulmonary hyper ension x       
Anxie y x       
Au oimmune encephalitis x       
Mechanosensation   x     
Cen ral modulation of pain x x     
Den al pain   x x   
Deafness     x   
Epilepsy x x   x 
GERD x x x   
Glaucoma x x     
Pulmonary hyper ension x       
Hunting on’s disease x x     
IBD x x x   
IBS x x x   
Parkinson’s disease x x     
Peripheral pain x   x   
Retinitis pigmen osa   x x   
Salivary gland carcinoma   x x   
S roke x       
Sour  as e sensing   x     
Table 2. Major Disease pathologies in which ASICs are potential therapeutic targets of investigation. 
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However, given  he wide expression of ASICs pro-
 eins and  heir direc  implication in multiple neuro-
logical and non- neurological disorders, i  would be 
surprising  ha   hese channel sub ypes form highly 
attractive  arge s for  he prediction of novel  reating 
ou comes. 
Pharmacological agents available  
Despi e  he fac   ha  ASICs are promising pharmaco-
logical  arge s, no po en  and selective ASIC inhibi ors 
besides  oxins are curren ly known. PhcrTx1 is  he 
firs  compound charac erized from  he sea anemone 
Phymanthus crucifer, and i  consti u es a novel ASIC 
inhibi or PhcrTx1 represen s  he firs  member of a 
new s ruc ural group of sea anemones  oxins acting 
on ASIC [58]. These  oxins have been ins rumen al  o 
s udy  he s ruc ure, properties, functional expression 
in above-mentioned physiopa hological s a es. Hcr1b-
1 and Hm3a bo h are peptide  oxins similar  o PcrTx1 
are ob ained from spider, snake and sea anemone 
venoms  argeting for ASICs [59-60]. Dendro oxins 
(DTx) are a group of peptide  oxins purified from  he 
venom of several mamba snakes and α-DTx selectivi y 
and i s po ential in eraction wi h ASICs should be  ak-
en in consideration for inhibiting ASICs induced 
curren  [61]. Recen ly discovered ASIC inhibi or 
compound 5b, one of  he mos  po en  inhibi ors 
known  o da e, lacks sub ype selectivi y [62]. Quer-
cetin, a plan  derived polyphenolic flavonoid com-
pound blocked homomeric ASIC1a, 2a and ASIC3 
wi h an IC50 of abou  2 mM [63]. 
Acid-sensing ion channels are direc ly modula ed by 
a varie y of compounds of syn hetic, endogenous 
and na ural origin. Chemically,  here are  hree clas-
ses of ASIC inhibi ors: me al ions, polypeptide  ox-
ins, and small-molecule inhibi ors. Besides Ca2+   and 
Mg2+, a number of divalen  and  rivalen  me al ions 
inhibi  ASICs. The bes  know syn hetic small molecule 
inhibi or of ASIC channels is amiloride, which inhibi s 
also o her  arge s and is a clinically used diuretic due 
 o i s inhibition of ENaC. O her molecules can also 
block ASIC channels wi h IC50 values 
of  he order of  ens  o hundreds of micromolar, in-
cluding A- 317567, non-s eroid anti- inflamma ory 
drugs, local anes hetics, vol age-ga ed K+ channel 
blockers like 4-aminopyridine, and a few o her com-
pounds (s rep omycin, neomycin, nafamos a  mesi-
la e, chloroquine and diarylamidines). Syn hetic mole-
cules like GMQ po entia e, or even activa e, ASICs. 
The mos  selective modula ors of ASIC channels are 
coming from animal venoms wi h highly selective cys-
 eine-rich high-affini y polypeptide  oxins  ha  inhibi  
(Mambalgins, and  o a cer ain ex en  APETx2) and 
sometimes activa e (Mi Tx)  hese channels [64]. I  
has been shown human painful inflamma ory exu-
da es, displaying non-acidic pH; induce a slow consti-
 utive activation of human ASIC3 channels. This effec  
is largely driven by lipids, and we identify lysophos-
phatidylcholine (LPC) and arachidonic acid (AA) as en-
dogenous activa ors of ASIC3 in  he absence of any 
ex racellular acidification [65]. 
CONCLUSIONS 
This mini review reveals pa hophysiological roles of 
ASICs and  heir  herapeutic candida es isola ed in 
differen  labora ories.  ASICs  are  con aining  in  all  
par s  of  human  body having immense desensitiza-
tion charac eristics,  pharmacological  properties and  
differen   abilities   o in erac  wi h in ra and ex ra-
cellular fac ors which are making  hemselves in 
fac  as like as a divers  herapeutic indications pur-
poses. These  o indica e  he ASIC channels an even 
more appealing drug  arge  however. The fac  is  ha , 
 he ASIC channels are involved in numerous physiolog-
ical and pa hological conditions,  heir unique charac-
 eristics  o allow exquisi e selectivi y makes  hem 
more appealing and attractive drug  arge  for seeking 
lead compounds  o predic   a  novel   rea men   ou -
come  for  severe  diseases  including  vasocon-
s riction,  angina, ischemic s roke, pain and inflamma-
tion, many psychia ric disorders and even in benign 
 umor grow h al eration. Since  he pharmacology of 
ASIC channels has made rapid progress in  he las  
years,  hereby few compounds have been isola ed ye  
from sources of drugs availabili y. Unfor una ely, still 
we don’  have  he selective and po en  ASICs modu-
la ed drug  o comba  diseases in upcoming days.  
Therefore,  in   his  review  I  have  wan ed   o  deliver  
a  message regarding  he vas  impor ance of new 
 herapeutic oppor unities of ASICs due  o  heir diverse 
pharmacological  implications.  I  would be good  o 
develop s ra egies of new screening approaches  o 
discover small selective molecules for  reating ASICs 
modula ed disease pa hogenesis and i  would be 
achieved by inhibiting as well as possibly stimulation 
of  hese ion channels. 
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